BioCentury
ARTICLE | Company News

Biocartis sales and marketing update

September 22, 2014 7:00 AM UTC

Biocartis launched its Idylla molecular diagnostics platform and Idylla BRAF Mutation Test in countries that accept CE Mark. Idylla is an automated, real-time PCR-based molecular diagnostics system t...